Table 1 Clinical characteristics of the prostate cancer patients
Gleason score | n (%) |
|---|---|
4-6 | 21 (35.6) |
7 | 15 (25.4) |
8-10 | 23 (39.0) |
PSA (ng/ml) | mean (SD) |
Radical prostatectomy patients (n = 31) | 9.1 (5.0) |
Other prostate cancer patients (n = 28) | 59 (169) |
Preoperative risk group | n (%) |
Low-risk group (cT1a-cT2a, N0, M0 and Gleason score ≤6 and PSA <10 ng/mL) | 7 (22.6) |
Intermediate-risk group (cT2b or PSA 10-20 ng/mL or Gleason score 7) | 16 (51.6) |
High-risk group (cT2c or higher or Gleason score >7 or PSA >20 ng/mL) | 8 (25.8) |